Flexion Therapeutics Inc (FLXN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
November 2018
49
About the Report
About the Report
Summary
Flexion Therapeutics Inc (Flexion) develops and commercializes pain therapies. The company's pipeline is focused on indications that includes osteoarthritis knee pain (repeat administration), osteoarthritis knee synovial inflammation, bilateral knee osteoarthritis pain shoulder and hip osteoarthritis pain and inflammatory conditions. The company's marketed product includes Zilretta which is the first and only extended-release, intra-articular therapy for patients confronting osteoarthritis-related knee pain. Flexion employs its proprietary microsphere technology to combine TA with a PLGA matrix for formulating Zilretta. It offers anti-inflammatory and analgesic therapies for osteoarthritis. Flexion is headquartered in Burlington, Massachusetts, the US.
Flexion Therapeutics Inc (FLXN)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Flexion Therapeutics Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Flexion Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Flexion Therapeutics Raises USD20 Million In Series B Financing 11
Flexion Therapeutics Raises Additional USD 13 Million In Series A Financing 12
Licensing Agreements 13
Flexion Therapeutics to Acquire Rights to GQ-203 13
Flexion Therapeutics Enters into Licensing Agreement with Southwest Research Institute 14
Equity Offering 15
Flexion Therapeutics Prices Public Offering of Shares for USD122.4 Million 15
Flexion Therapeutics Raises USD74.5 Million in Public Offering of Shares 17
Flexion Therapeutics Raises USD82.6 Million in Public Offering of Shares 19
Flexion Therapeutics Raises USD98.5 Million in Public Offering of Shares 21
Flexion Therapeutics Completes IPO For USD 74.7 Million 23
Debt Offering 25
Flexion Therapeutics Raises USD201.3 Million in Private Placement of 3.375% Notes Due 2024 25
Acquisition 26
Sanofi May Acquire Flexion Therapeutics for up to USD1 Billion 26
Flexion Therapeutics Inc-Key Competitors 27
Flexion Therapeutics Inc-Key Employees 28
Flexion Therapeutics Inc-Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Financial Announcements 30
Nov 07, 2018: Flexion Therapeutics reports third-quarter 2018 financial results and recent business highlights 30
Aug 07, 2018: Flexion Therapeutics reports second-quarter 2018 financial results and recent business highlights 32
May 08, 2018: Flexion Therapeutics Reports First-Quarter 2018 Financial Results and Recent Business Highlights 34
Mar 08, 2018: Flexion Therapeutics Reports Full Year 2017 Financial Results 36
Nov 06, 2017: Flexion Therapeutics Reports Third-Quarter 2017 Financial Results and Recent Business Highlights 37
Aug 08, 2017: Flexion Therapeutics Reports Second Quarter 2017 Financial Results and Recent Business Highlights 38
May 04, 2017: Flexion Therapeutics Reports First Quarter 2017 Financial Results and Recent Business Highlights 39
Mar 09, 2017: Flexion Reports Year-End 2016 Financial Results 40
Corporate Communications 41
May 07, 2018: Flexion Therapeutics Appoints David Arkowitz As Chief Financial Officer 41
Dec 12, 2017: Flexion Therapeutics Announces Appointment of Scott Kelley, M.D. as CMO 42
Dec 11, 2017: Flexion Therapeutics Announces Appointment of Scott Kelley, M.D. as Chief Medical Officer 43
Jun 28, 2017: Flexion Therapeutics appoints new senior vice president, general counsel and secretary 44
Apr 07, 2017: Flexion Therapeutics Announces Appointment of Yamo Deniz, MD, as Chief Medical Officer 45
Product News 46
07/31/2018: New gene therapy treatment for osteoarthritis 46
07/10/2017: Flexion Therapeutics: Update on FX101 47
Clinical Trials 48
Apr 29, 2018: Flexion Therapeutics Announces Presentation of Positive FX201 Data at the Osteoarthritis Research Society International World Congress 48
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49
List of Figure
List of Figures
Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
List of Table
List of Tables
Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Flexion Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Flexion Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Flexion Therapeutics Raises USD20 Million In Series B Financing 11
Flexion Therapeutics Raises Additional USD 13 Million In Series A Financing 12
Flexion Therapeutics to Acquire Rights to GQ-203 13
Flexion Therapeutics Enters into Licensing Agreement with Southwest Research Institute 14
Flexion Therapeutics Prices Public Offering of Shares for USD122.4 Million 15
Flexion Therapeutics Raises USD74.5 Million in Public Offering of Shares 17
Flexion Therapeutics Raises USD82.6 Million in Public Offering of Shares 19
Flexion Therapeutics Raises USD98.5 Million in Public Offering of Shares 21
Flexion Therapeutics Completes IPO For USD 74.7 Million 23
Flexion Therapeutics Raises USD201.3 Million in Private Placement of 3.375% Notes Due 2024 25
Sanofi May Acquire Flexion Therapeutics for up to USD1 Billion 26
Flexion Therapeutics Inc, Key Competitors 27
Flexion Therapeutics Inc, Key Employees 28
Flexion Therapeutics Inc, Subsidiaries 29
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.